Empowering Patients' Lung Cancer Screening Uptake

Completed · Not applicable

Conditions studied: Lung Cancer

In brief

Lung cancer is the leading cause of cancer related mortality. Lung cancer screening (LCS) with low dose computed tomography (LDCT) decreases mortality rate of lung cancer by 20%. Yet many patients who are eligible for lung cancer screening are still falling through the cracks which prevents patients the ability to detect lung cancer early. This study will test the effect of a a multi-level intervention on ordering LDCT within 6 months after patient enrollment. Our proposed intervention includes (1) Primary care provider notifications of patients' LCS eligibility; (2) patients' education ; (3) patients' referral to financial navigation resources; and (4) patients' reminder to discuss LCS during PCP visit.

Key facts

Study ID

NCT06000683

Run by

University of California, Irvine

People needed

79

Starts

2023-10-13

Expected to finish

2025-11-25

Last updated by the study team

2026-02-20

Who can join

Age: 50 and older, up to 80. Sex: any. Healthy volunteers: accepted.

Where it is running

• UCI Health - Costa Mesa — Costa Mesa, California, United States
• UCI Health Gottschalk Medical Plaza — Irvine, California, United States
• UCI Health - Laguna Hills — Laguna Hills, California, United States
• UCI Health - Newport Beach MacArthur — Newport Beach, California, United States
• UCI Medical Center — Orange, California, United States
• UCI Health - Tustin — Tustin, California, United States
• UCI Health-Yorba Linda — Yorba Linda, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.